RIT1 and cancer: Pharmacological RAF inhibition abolished MAPK activation induced by ectopic RIT1 expression, including RIT1Q79L (a constitutively active mutant analogous to RASQ61L), and a panel of NS and cancer-associated variants with variable levels of GTP-loading in cells (Fig. 1A) (13).